-
Income: $621.four million (up 22% from Q3 2023).
-
Web loss: $31.2 million (loss decreased 5.9% from Q3 2023).
-
Lack of $zero.27 per share (improved from lack of $zero.30 in Q3 2023).
All figures proven within the desk above correspond to the interval of the final 12 months (TTM)
Income was in keeping with analyst estimates. Earnings per share (EPS) missed analyst estimates.
Trying forward, income is forecast to develop 14% yearly on common over the following three years, in comparison with a projected 9.9% progress for the healthcare providers trade within the US.
Efficiency of the American healthcare trade.
The corporate's shares are down 43% in comparison with per week in the past.
The ever-present specter of funding danger nonetheless must be thought-about. Now we have recognized 1 warning signal with Evolent Well being, and understanding this ought to be a part of your funding course of.
Do you’ve gotten any feedback about this text? Nervous about content material? Get in contact with us straight. Alternatively, electronic mail the editorial workforce (at) Simplywallst.com.
This Merely Wall St article is basic in nature. We offer commentary based mostly on historic knowledge and analyst forecasts utilizing solely unbiased methodology and our articles are usually not meant to be monetary recommendation. It doesn’t represent a suggestion to purchase or promote shares and doesn’t consider your aims or monetary scenario. Our aim is to offer you targeted, long-term evaluation pushed by basic knowledge. Please observe that our evaluation might not consider the newest bulletins from price-sensitive corporations or qualitative materials. Merely Wall St has no place in any of the shares talked about.